UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Evaluation of the ELITechGroup solution for plasma HIV-1 RNA quantification

Journal of clinical virology, 2024-08, Vol.173, p.105663-105663, Article 105663

2024

Volltextzugriff (PDF)

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

Kidney international, 2021-12, Vol.100 (6), p.1337-1340

2021

Volltextzugriff (PDF)

Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients

Kidney international, 2022-08, Vol.102 (2), p.440-442

2022

Volltextzugriff (PDF)

The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection

Journal of clinical virology, 2012-10, Vol.55 (2), p.121-127

2012

Volltextzugriff (PDF)

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023

Euro surveillance : bulletin européen sur les maladies transmissibles, 2023-06, Vol.28 (22), p.1

2023

Volltextzugriff (PDF)

Performance evaluation of the Access anti-HBc Total assay on the DxI 9000 Access Immunoassay Analyzer

Diagnostic microbiology and infectious disease, 2024-09, Vol.110 (1), p.116303, Article 116303

2024

Volltextzugriff (PDF)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine

Clinical kidney journal, 2022-12, Vol.15 (12), p.2343-2345

2022

Volltextzugriff (PDF)

Detection of numerous HIV-1/MO recombinants in France

AIDS (London), 2018-06, Vol.32 (10), p.1289-1299

2018

Volltextzugriff (PDF)

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

Microorganisms (Basel), 2024-04, Vol.12 (4), p.722

2024

Volltextzugriff (PDF)

Invasive meningoencephalitis as the first manifestation of hepatitis A

Journal of viral hepatitis, 2019-11, Vol.26 (11), p.1330-1333

2019

Volltextzugriff (PDF)

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer

Practical laboratory medicine, 2024-03, Vol.39, p.e00390-e00390, Article e00390

2024

Volltextzugriff (PDF)

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients

Clinical kidney journal, 2021-09, Vol.14 (9), p.2127-2128

2021

Volltextzugriff (PDF)

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023 separator commenting unavailable

Euro surveillance : bulletin européen sur les maladies transmissibles, 2023-06, Vol.28 (22), p.1

2023

Volltextzugriff (PDF)

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Heliyon, 2024-05, Vol.10 (10), p.e29591, Article e29591

2024

Volltextzugriff (PDF)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine

Clinical kidney journal, 2022-12, Vol.15 (12), p.2343

2022

Volltextzugriff (PDF)

Evaluation of the Aptima HIV-1 Quant Dx assay on a wide panel of HIV-1 strains: Presentation at ESCV 2016: Poster 34

Journal of clinical virology, 2016-09, Vol.82, p.S38-S38

2016

Volltextzugriff (PDF)

Evaluation of the Aptima HIV-1 Quant Dx assay on a wide panel of HIV-1 strains

Journal of clinical virology, 2016-09, Vol.82, p.S38-S38

2016

Volltextzugriff (PDF)

Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTi m e HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants

Journal of clinical virology, 2015, Vol.71, p.76-81

2015

Volltextzugriff (PDF)

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon: e1005029

PLoS pathogens, 2015-08, Vol.11 (8)

2015

Volltextzugriff (PDF)

HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsResearch in context

EBioMedicine, 2018-11, Vol.37, p.382-391

2018

Volltextzugriff (PDF)

Performance of the Liaison XL Murex HIV Ab/Ag Test on Clinical Samples Representing Current Epidemic HIV Variants: TABLE 1

Journal of clinical microbiology, 2014-08, Vol.52 (9), p.3277-3279

2014

Volltextzugriff (PDF)

Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients

Kidney international, 2022-05

2022

Volltextzugriff (PDF)

First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2024, Vol.30 (5), p.691-693

2024

Volltextzugriff (PDF)

First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon

AIDS (London, England), 2010, Vol.24 (7), p.1079-1082

2010

Volltextzugriff (PDF)

HIV-1 group M superinfection in an HIV-1 group O-infected patient

AIDS (London, England), 2004, Vol.18 (18), p.2444-2446

2004

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of the ELITechGroup solution for plasma HIV-1 RNA quantification

Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients

Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients

The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023

Performance evaluation of the Access anti-HBc Total assay on the DxI 9000 Access Immunoassay Analyzer

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine

Detection of numerous HIV-1/MO recombinants in France

Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster Dose

Invasive meningoencephalitis as the first manifestation of hepatitis A

Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access Immunoassay Analyzer

Antibody response to SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients and in-centre and satellite centre haemodialysis patients

Severe and fatal neonatal infections linked to a new variant of echovirus 11, France, July 2022 to April 2023 separator commenting unavailable

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine

Evaluation of the Aptima HIV-1 Quant Dx assay on a wide panel of HIV-1 strains: Presentation at ESCV 2016: Poster 34

Evaluation of the Aptima HIV-1 Quant Dx assay on a wide panel of HIV-1 strains

Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTi m e HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon: e1005029

HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendorsResearch in context

Performance of the Liaison XL Murex HIV Ab/Ag Test on Clinical Samples Representing Current Epidemic HIV Variants: TABLE 1

Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients

First evidence of a mother-to-child transmission of an HIV-1/MO intergroup recombinant form

First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon

HIV-1 group M superinfection in an HIV-1 group O-infected patient

Aktive Filter

Suchergebnisse filtern